Compare AU

Compare BNDS vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Westn Asset Aus Bond Fund (Managed Fund)

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Westn Asset Aus Bond Fund (Managed Fund) (BNDS) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

BNDS

DRUG

Popularity

Low

Low

Pearlers invested

13

61

Median incremental investment

$707.68

$920.50

Median investment frequency

Monthly

Monthly

Median total investment

$916.50

$1,892.10

Average age group

> 35

26 - 35


Key Summary

BNDS

DRUG

Strategy

BNDS.AX was created on 2018-11-07 by BetaShares. The fund's investment portfolio concentrates primarily on broad credit fixed income. The Fund aims to earn an after fee return in excess of the Bloomberg AusBond Composite 0+yr Index over rolling three year periods.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

AUSTRALIAN GOVERNMENT 2.75% MAY-41 (2.26 %)

AUSTRALIAN GOVERNMENT 3.5% DEC-34 (1.63 %)

AUSTRALIAN GOVERNMENT 3.75% MAY-34 (1.61 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Other (99.56 %)

Communication Services (0.44 %)

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.42 %

0.57 %


Key Summary

BNDS

DRUG

Issuer

BetaShares

BetaShares

Tracking index

Bloomberg AusBond Composite Index - AUD

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.42 %

0.57 %

Price

$23.50

$7.95

Size

$786.559 million

$185.172 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

2.44 %

1.90 %

Market

ASX

ASX

First listed date

16/11/2018

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

BNDS

DRUG

Popularity

Low

Low

Pearlers invested

13

61

Median incremental investment

$707.68

$920.50

Median investment frequency

Monthly

Monthly

Median total investment

$916.50

$1,892.10

Average age group

> 35

26 - 35


Pros and Cons

BNDS

DRUG

Pros

  • Lower management fee

  • Higher distribution yield

  • Higher exposure to US market

  • Higher price growth

Cons

  • Lower exposure to US market

  • Lower price growth

  • Higher management fee

  • Lower distribution yield

BNDS

DRUG

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home